Ablexis, LLC Sustainability Profile
Ablexis, LLC, a pioneering biotechnology company headquartered in the United States, has been at the forefront of antibody discovery since its establishment in 2010. With a strong operational presence across North America and Europe, Ablexis focuses on developing innovative solutions for therapeutic antibody generation, utilising its proprietary AlivaMab® platform. The company’s core offerings include the AlivaMab platform, which enables the rapid and efficient creation of fully human monoclonal antibodies. This unique technology streamlines the drug development process, significantly reducing time and costs for clients in the pharmaceutical and biotechnology sectors. Recognised for its contributions to the industry, Ablexis has established a solid market position, collaborating with leading biopharmaceutical companies to advance therapeutic options for various diseases. With a commitment to innovation and excellence, Ablexis continues to shape the future of antibody therapeutics.
DitchCarbon Score
How does Ablexis, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ablexis, LLC's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ablexis, LLC's reported carbon emissions
Ablexis, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Ablexis may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company does not inherit any emissions data or targets from a parent organisation, and there are no industry-standard climate commitments reported.
How Carbon Intensive is Ablexis, LLC's Industry?
How Carbon Intensive is Ablexis, LLC's Location?
Ablexis, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ablexis, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
